Status:
RECRUITING
Early Discharge Pathway Registry
Lead Sponsor:
Queen Mary University of London
Conditions:
Myocardial Infarction
ST Elevation Myocardial Infarction
Eligibility:
All Genders
16+ years
Brief Summary
Despite the year-on-year decrease, coronary artery disease (CAD) still remains one of the leading causes of mortality worldwide. With advances in technology and our understanding of cardiac disease, w...
Detailed Description
The proposed study includes one of the largest coronary interventional programmes in the UK at Europe's largest cardiac centre (BHC). This has allowed us to accumulate a large number of patients in ju...
Eligibility Criteria
Inclusion
- Informed consent will not be sought for, as patients are automatically included onto a database that we will use for research purposes. No children will be included in this study. Vulnerable adults or those unable to give consent will be included in the study as well if they are referred to the Interventional Cardiology team.
- Both male and female patients ≥16 years of age will be included
- All patients will have been admitted to BHC with acute coronary syndrome.
Exclusion
- Patients \<16 years will not be included in this study.
Key Trial Info
Start Date :
November 11 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT06040528
Start Date
November 11 2023
End Date
December 31 2026
Last Update
January 7 2026
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Barts Health NHS Trust
London, United Kingdom
2
Dr. Daniel Jones
London, United Kingdom